-
1.
公开(公告)号:EP4313938A1
公开(公告)日:2024-02-07
申请号:EP22716644.4
申请日:2022-03-23
申请人: Modernatx, Inc.
发明人: BENENATO, Kerry E. , CORNEBISE, Mark , HENNESSY, Edward , SEEPERSAUD, Mohindra , DANNEMAN, Michael W.
IPC分类号: C07C233/36 , C07C233/38 , C07C233/40 , C07C233/58 , C07C233/78 , C07C235/10 , C07C235/40 , C07C237/22 , C07C311/05 , C07C311/24 , C07D205/04 , C07D213/74 , C07D261/08 , C07D271/04 , C07D285/10 , C07D307/24 , C07D309/08 , A61K9/00
-
公开(公告)号:EP3759085B1
公开(公告)日:2022-12-14
申请号:EP19710262.7
申请日:2019-02-26
发明人: BASINGER, THOMPSON, Jillian , BOOKSER, Brett , BURLEY, Scott , GARCIA-REYNAGA, Pablo , HUDSON, Andrew , PETERS, Marco , PRATT, Benjamin , THOMPSON, Aaron , TRAN, Joe , VALDEZ, Lino
IPC分类号: C07C211/37 , C07C215/44 , C07C237/24 , C07C255/46 , C07D309/08 , C07D309/14 , C07C211/35 , C07D207/09 , C07D211/72 , C07D213/24 , C07D307/16
-
公开(公告)号:EP4051669A1
公开(公告)日:2022-09-07
申请号:EP20883108.1
申请日:2020-10-28
发明人: REN, Zaifang , SUN, Xuefeng , XU, Qing
IPC分类号: C07D309/04 , C07D319/12 , C07D309/10 , C07D309/08 , C07C317/14 , C07D307/10 , C07D309/12 , C07D211/46 , C07D309/06 , C07D205/04 , C07D275/02 , C07D207/06 , C07D401/04 , C07D295/08 , A61K31/10 , A61P3/00 , A61P9/00 , A61P29/00
-
公开(公告)号:EP3971166A1
公开(公告)日:2022-03-23
申请号:EP21206301.0
申请日:2017-10-09
发明人: HEEMSTRA, Ronald J. , ROSS, Ronald , MARTIN, Timothy P. , VERMEULEN, Nicolaas , DAEUBLE, John F. , ECKELBARGER, Joseph D. , NOLAN, Alex , GRAY, Kaitlyn , DEMETER, David A. , HUNTER, Ricky , TRULLINGER, Tony K.
IPC分类号: C07C237/42 , A01N53/00 , C07C255/19 , C07C255/46 , C07C255/60 , C07C271/28 , C07C271/66 , C07C311/10 , C07D207/16 , C07D231/14 , C07D261/18 , C07D275/03 , C07D307/24 , C07D307/68 , C07D309/08 , C07D333/38
摘要: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula ("Formula One").
-
公开(公告)号:EP3578547B1
公开(公告)日:2021-05-26
申请号:EP19187141.7
申请日:2016-02-16
发明人: O'NEILL, Luke , COOPER, Matthew , ROBERTSON, Avril , SCHRODER, Kate ,
IPC分类号: C07D231/18 , C07D307/64 , C07D311/60 , C07D407/12 , C07D405/12 , C07D403/12 , C07D213/71 , C07D217/22 , C07D249/12 , C07D271/12 , C07D333/34 , C07D277/36 , C07D333/62 , C07D249/04 , C07D417/12 , C07D307/82 , C07C311/54 , C07C311/56 , C07D307/18 , C07D309/08
-
公开(公告)号:EP3189050B1
公开(公告)日:2020-02-05
申请号:EP15837720.0
申请日:2015-09-07
申请人: Griffith University
IPC分类号: A61K31/351 , A61K31/36 , A61K31/4025 , A61K31/403 , A61K31/41 , A61K31/4192 , C07D405/14 , C07D309/28 , C07D405/04 , C07D407/12 , C07D309/08 , A61P31/14 , A61P31/16
-
公开(公告)号:EP3092221B1
公开(公告)日:2018-10-17
申请号:EP15700818.6
申请日:2015-01-05
发明人: DUAN, Jingwu , DHAR, T.G. Murali , JIANG, Bin , KARMAKAR, Ananta , GUPTA, Arun Kumar , LU, Zhonghui
IPC分类号: C07D309/08 , C07D401/06 , C07D405/06 , C07D211/54 , A61K31/4545 , A61K31/445 , A61K31/453 , A61K31/496 , A61K31/35 , A61P11/06 , A61P35/00 , A61P3/00 , A61P17/06 , A61P37/08
CPC分类号: C07D211/54 , C07D211/96 , C07D309/08 , C07D401/06 , C07D405/06
摘要: Described are RORγ modulators of the formula (I), [INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ activity, for example, autoimmune and/or inflammatory disorders.
-
公开(公告)号:EP3092215B1
公开(公告)日:2018-10-17
申请号:EP15700816.0
申请日:2015-01-05
发明人: DUAN, Jingwu , DHAR, T. G. Murali , JIANG, Bin , KARMAKAR, Ananta , GUPTA, Arun Kumar , LU, Zhonghui , WEIGELT, Carolyn A.
IPC分类号: C07D213/04 , C07D309/08 , C07D231/10 , C07D401/02 , C07D403/04 , C07D237/08 , C07D405/02 , C07C317/00 , C07D239/28 , C07D241/24 , C07D249/04 , C07D471/04 , C07D205/04 , C07D207/277 , C07D277/60 , C07D211/36 , C07D295/18 , A61K31/10 , A61K31/33 , A61P29/00
CPC分类号: C07C317/20 , C07C317/24 , C07C317/30 , C07C317/46 , C07C2601/02 , C07C2601/14 , C07D205/04 , C07D207/27 , C07D207/277 , C07D211/46 , C07D211/48 , C07D211/62 , C07D211/78 , C07D213/30 , C07D213/40 , C07D213/56 , C07D213/71 , C07D213/75 , C07D213/81 , C07D213/82 , C07D231/12 , C07D231/14 , C07D231/54 , C07D231/56 , C07D237/08 , C07D237/20 , C07D237/22 , C07D237/24 , C07D239/28 , C07D241/24 , C07D249/04 , C07D249/06 , C07D277/60 , C07D277/82 , C07D295/096 , C07D295/16 , C07D295/185 , C07D295/195 , C07D295/205 , C07D309/04 , C07D309/08 , C07D335/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D405/04 , C07D471/04
摘要: Described are RORϒ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORϒ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORϒ activity, for example, autoimmune and/or inflammatory disorders.
-
公开(公告)号:EP3259253A1
公开(公告)日:2017-12-27
申请号:EP16751821.6
申请日:2016-02-16
申请人: The University Of Queensland , The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth
IPC分类号: C07D231/18 , C07D307/64 , C07D311/60 , C07D407/12 , C07D405/12 , C07D403/12 , C07D213/71 , C07D217/22 , C07D249/12 , C07D271/12 , C07D333/34 , C07D277/36 , C07D333/62 , C07D249/04 , C07D417/12 , C07D307/82 , C07C311/54 , C07C311/56 , C07D307/18 , C07D309/08
摘要: The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
-
公开(公告)号:EP2964616B1
公开(公告)日:2017-05-03
申请号:EP14713656
申请日:2014-03-04
发明人: FENSTER ERIK , FLEURY MELISSA , HUGHES ADAM D
IPC分类号: C07D213/75 , A61K31/197 , A61K31/4015 , A61K31/42 , A61K31/495 , A61K31/5375 , C07C235/78 , C07C243/38 , C07C259/04 , C07D205/04 , C07D207/16 , C07D211/62 , C07D233/06 , C07D239/36 , C07D261/04 , C07D265/30 , C07D295/32 , C07D307/68 , C07D309/08 , C07D401/04 , C07D491/107
CPC分类号: C07C243/38 , A61K31/192 , A61K31/197 , A61K31/341 , A61K31/397 , A61K31/40 , A61K31/4015 , A61K31/42 , A61K31/44 , A61K31/4406 , A61K31/4409 , A61K31/495 , A61K31/5375 , A61K45/06 , C07C233/56 , C07C235/12 , C07C235/20 , C07C235/34 , C07C235/74 , C07C235/78 , C07C235/80 , C07C243/24 , C07C243/32 , C07C259/04 , C07C2601/08 , C07C2601/16 , C07D205/04 , C07D207/08 , C07D207/09 , C07D207/12 , C07D207/14 , C07D207/16 , C07D211/22 , C07D211/38 , C07D211/42 , C07D211/46 , C07D211/48 , C07D211/60 , C07D211/62 , C07D213/56 , C07D213/61 , C07D213/65 , C07D213/75 , C07D213/86 , C07D213/87 , C07D233/06 , C07D239/36 , C07D261/02 , C07D261/04 , C07D265/30 , C07D295/32 , C07D307/68 , C07D309/08 , C07D401/04 , C07D405/06 , C07D491/107 , C07D493/10
摘要: In one aspect, the invention relates to compounds having the formula: where R1-R5 and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
摘要翻译: 一方面,本发明涉及具有下式的化合物:其中R1-R5和X如说明书中所定义,或其药学上可接受的盐。 这些化合物具有尿丙氨酸抑制活性。 另一方面,本发明涉及包含这些化合物的药物组合物; 使用这些化合物的方法; 以及制备这些化合物的方法和中间体。
-
-
-
-
-
-
-
-
-